For Review Only LATEST ONCOPRESCRIBE UPDATES Expansion of Cancer Risk Profile beyond Breast and Ovarian Cancer for BRCA1 and BRCA2 Pathogenic VariantsSegmentectomy versus Lobectomy in Small-Sized Peripheral Non-Small Cell Lung CancerFDA Grants Regular Approval to ENHERTU® for Breast CancerLower Gastrointestinal Endoscopy before Age 50 Years Reduces Risk for Colorectal Cancer among Women SHOW MORE FDAApprovals Meeting Updates Hem/OncUpdates Symptom Management NEW REGIMENS ADDEDResearch RegimensSingle Agent PEMAZYRE® - for CholangiocarcinomaPARAPLATIN® and VEPESID® with IMFINZI® - for Small Cell Lung CancerIMFINZI® Maintenance - Small Cell Lung CancerTECENTRIQ® and ABRAXANE® - for Breast CancerIDHIFA® - for Acute Myeloid Leukemia Curbside Consultation Breast Cancer Special Issue Immuno-Oncology Precision Oncology COVID-19 Associated Coagulopathy: Diagnosis and ManagementDual Inhibition Improves Outcomes for Patients with BRAF-Mutated Colorectal TumorsReduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningFDA Approves ENDARI®, A New Treatment for Sickle Cell DiseaseSHOW MORE